Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

Researchers from Keele University have said there are multiple barriers preventing clinicians from prescribing alternative treatments for asthma patients, despite guidance calling for a move toward ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

AptarGroup (ATR) announced the commencement of a clinical study to validate its proprietary SmartTrack platform. The platform was developed by ...

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

Aim: (1) To compare the efficacy and adverse effects of treatment using nebulizers vs pressurized metered-dose inhalers (MDIs) with or without a spacer/holding chamber vs dry powder inhalers (DPIs ...

The study will involve radio-labeling three different commercially available pressurized metered-dose inhaler (pMDI) drug products to image lung deposition. These results will be compared with ...